Davion Healthcare Plc DAVI

$1.58 -0.17 (-9.71%)

Valuation

Market cap
43,750,000
Revenue TTM
$0
Net income TTM
$-1,128,807
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
163,200
Avg volume
—
Day's range
$1.57 – $1.76
Shares out
25,000,000
Stochastic %K
14%
Beta
—
Analysts
—
Price target
—

Price

Company profile

Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company's flagship product, BreastCheck, is an FDA-registered at-home breast health screenin...

Show more

Davion Healthcare Plc, a digital healthcare company, engages in the design, development, and commercialization of non-invasive health monitoring technologies. Its core consumer health portfolio comprises proprietary, home-based monitoring devices designed to support the early identification of potential medical anomalies. The company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. It is also developing a portfolio of proprietary health monitoring technologies, including FootFlow for monitoring indicators associated with circulation and diabetes-related blood flow issues; Testic, an at-home testicular health monitoring system; and ThermaDerm for the identification of skin anomalies, as well as technologies addressing wound monitoring, blood pressure, and other areas of preventive healthcare. The company was incorporated in 2022 and is based in Cork, Ireland.

Industry
Medical Instruments & Supplies
Sector
Healthcare
Phone
353 238 808 958
Website
https://www.davionhealthcare.com
Address
West Cork Business & Technology Park, Unit A Clonakilty, Cork, Ireland

Latest news

No headlines yet.